PTSD Clinical Trial
Official title:
Memory and the Hippocampus in Vietnam Twins With PTSD
The purpose of this project is to measure brain markers and cognitive factors in twins with a history of military service with and without PTSD, and to follow them over time and measure changes in brain function and cognitive variables.
Posttraumatic stress disorder (PTSD) is a condition of critical importance to the Veterans
Health Administration that affects up to 15% of Vietnam combat veterans.1 Studies in animals
demonstrated that stress is associated with alterations in the morphology of the
hippocampus, a brain structure involved in learning and memory, as well as memory deficits.
Patients with PTSD have smaller hippocampal volume on magnetic resonance imaging (MRI) and
deficits in memory on neuropsychological testing. Animal models also show a progressive
diminution of hippocampal volume with normal aging that is associated with a loss of memory
function. In humans, in very old age in some individuals the hippocampus becomes smaller,
with associated declines in memory function. Clinically, PTSD patients appear to have a more
rapid rate of memory decline with age, which has led to their being characterized as having
an "accelerated aging"; however there is little empiric data related to the interaction
between normal aging and PTSD and its effect on memory. In the prior period of VA Merit
funding the PI has studied memory and the hippocampus in twin pairs discordant for PTSD as
well as normal twin pairs. We have studied 42 MZ and DZ twin pairs discordant for Vietnam
theater exposure and discordant for PTSD and 28 MZ and DZ twin pairs concordant for Vietnam
theater exposure and discordant for PTSD. All twins underwent measures of hippocampal
volume, neuropsychological testing, and cortisol. A subset of 10 pairs of MZ pairs
discordant for PTSD and combat exposure underwent positron emission tomography (PET) imaging
of neural correlates of declarative memory function. Preliminary analyses are consistent
with smaller hippocampal volume and deficits in verbal declarative memory in PTSD affected
twins compared to their non-PTSD brothers who were not exposed to Vietnam combat.
We now propose to measure hippocampal volume, memory function, and neural correlates of
declarative memory, in MZ and DZ twins previously studied, who are discordant for combat and
PTSD. We will study 42 twin pairs who were studied during 1999-2003, of whom 34 were
discordant for PTSD at the Atlanta based assessment and had all study data including MRI,
neuropsychological testing, and cortisol (with PET in a subsample of 10 pairs), with repeat
measurements performed 8 years after the initial assessment, a time of life when they become
vulnerable to memory decline associated with aging (subjects not discordant for PTSD at the
Atlanta based assessment will also be studied as a comparison). These assessments will allow
a comprehensive assessment of the relative impact of shared environment (e.g. family life),
unique environment (Vietnam theater service), and genetics on the outcomes of interest. We
hypothesize that there will be an interaction between PTSD diagnosis and aging, i.e. PTSD
patients relative to non-PTSD will show smaller hippocampal volume as measured with MRI,
deficits in verbal declarative memory as measured with neuropsychological testing, lower
cortisol, and a failure of hippocampal function during memory tasks as measured with PET,
and that the rate of decline will be greater in PTSD v non PTSD. We further hypothesize that
analysis of all twin pair combinations will show a combined impact of genetics and PTSD
diagnosis on the hippocampal outcomes of interest.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03962504 -
Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial
|
N/A | |
Completed |
NCT01995123 -
Behavioral Activation for Smoking Cessation in PTSD
|
N/A | |
Not yet recruiting |
NCT06278922 -
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
|
N/A | |
Completed |
NCT04597450 -
Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)
|
Phase 1 | |
Completed |
NCT03593772 -
Mission Reconnect- Delivering a Mobile and Web Based Self Directed Complementary And Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD
|
N/A | |
Completed |
NCT03429166 -
Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas
|
N/A | |
Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT03504722 -
Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD
|
N/A | |
Completed |
NCT04305353 -
Intensive Care Unit (ICU) Diary Project
|
N/A | |
Completed |
NCT03113890 -
McLean and Genomind Prospective Study
|
N/A | |
Withdrawn |
NCT05173831 -
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
|
Phase 2 | |
Not yet recruiting |
NCT04056767 -
Changes in Digital Phenotype During PE Therapy
|
||
Withdrawn |
NCT03924297 -
Chilipad for Sleep and Symptoms of PTSD
|
N/A | |
Completed |
NCT03158558 -
Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD
|
N/A | |
Withdrawn |
NCT03216356 -
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD
|
Phase 2/Phase 3 | |
Completed |
NCT03343028 -
Biomarker Establishment for Superior Treatment of PTSD
|
||
Completed |
NCT02370173 -
A Non-Pharmacological Method for Enhancing Sleep in PTSD
|
N/A | |
Completed |
NCT01911585 -
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
|
N/A | |
Completed |
NCT01955538 -
The Effect of BAT Versus Mixed Physical Activity as add-on Treatment for Traumatised Refugees.
|
Phase 3 |